Among the first 400 patients undergoing saphenous vein coronary artery bypass at Stanford Medical Center, 67 (18%) met criteria for "preinfarction angina". Angina was alleviated and possible myocardial infarction was prevented utilizing these surgical technics. The overall operative mortality rate in the preinfarction angina patients was 10.4%, which contrasted strikingly with a 1.5% operative mortality for elective coronary artery bypass at Stanford. Six of the seven operative deaths resulted from myocardial infarction, two of which were related to technical factors. Operative mortality appeared to be related to degree of preoperative congestive heart failure and hypotension, pump time, sex, and number of atherosclerosis risk factors present. Fifty-two of the 60 patients leaving the hospital (87%) received good symptomatic benefit from surgery, including no late infarction, over a 6.8 month mean follow-ulp period. The late death rate was 3.3%, and the late infarction rate was 10% during the follow-up period. Angina can be alleviated and impending myocardial infarction may be prevented with aggressive surgical intervention.
S INCE 1967, aortocoronary saphenous vein
bypass has been utilized widely for the surgical treatment of patients suffering from ischemic heart disease.1-' The predominant surgical indication for this procedure has been angina pectoris; however, saphenous vein bypass has also been employed with varying degrees of success in patients with ".preinfaretion angina," acute myocardial infarction, treatment of atherosclerotic coronary arterial disease during the past 27 months.
Among the first 400 patients to receive bypass grafts at Stanford Medical Center, 18% (67 patients) had preinfaretion angina, as defined below, and underwent operation on an emergency basis to treat refractory angina and to attempt to prevent myocardial infarction with its ominous complications. The results in these 67 patients are described in this report.
Methods and Materials

Definitions
The symtomatology of ischemic heart disease encompasses a spectrum of clinical syndromes. Clearly, there is a transitional stage which represents a precarious state of imbalance between myocardial oxygen supply and metabolic demand. However, in many cases, it is difficult to differentiate clinically between myocardial ischemia and actual cell necrosis. Even sophisticated histochemical and electron microscopic technics reveal an intermediate zone. 22- Of the total 42 individual grafts reinjected, seven were closed (four LADs and three in combination with RCA endarterectomy). Only two patients have been restudied after late infarctions; two of the three grafts which had been placed were patent, but diffuse progression of the coronary artery disease was evidenced in both cases.
Discussion
A large number of clinical reports dealing with coronary artery bypass for preinfarction angina have recently been published. [1] [2] [3] [4] [5] [6] [7] Most series have been too small to enable one to reach any firm conclusions. Until current well-constructed, doubleblind prospective studies are completed, the true natural history of the preinfarction syndrome will remain unknown. We believe that this series represents a homogeneous subpopulation of patients with coronary artery disease which can be validly termed "preinfarction angina."
In various reports, it has been shown that men with stable angina pectoris are exposed to a yearly mortality of between 5 and 9%, and that more than one out of four can be expected to suffer a myocardial infarct within 5 years.3°-2 The age of the patients, the severity of the disease, and other health factors, account for the various infarction and death rates. The prognosis for those with an unstable angina picture is known to be worse.33 34 In some studies, between 22 and 50% of these patients progress within 3 months to infarction, with an associated mortality of 30%.35 36 Anticoagulation in these patients still exposes them to an infarction rate of between 11 and 33%.37-39 The recent observations of DeSanctis and colleagues, which are the most optimistic for these patients with unstable angina, show a mortality rate of 14%40 during the first follow-up year.
Those acute myocardial infarction patients who are rapidly admitted to a modern Coronary Care
Unit are still subject to a mortality rate of approximately 20% within 30 days. For those who survive their acute infarction, long-term disability is still present in 10-15%. In view of our experience, we believe that early study and aggressive emergency surgical intervention is feasible for patients with preinfarction angina. The therapeutic goal is the relief of angina pectoris, as well as the prevention of infarction and preservation of the functional integrity of the left ventricle. It is interesting to note that, despite our aggressive approach to preinfarction angina at Stanford, seven preinfarction patients here have died of massive infarction before surgical intervention could be carried out.
In this series of 59 patients with uncomplicated preinfarction angina, the operative mortality was 8.5%, and in the overall group of 67 was 10.4%. This contrasts with rates of 0-19% reported in other large series.6-11 The wide variation in operative mortality reported for patients with this syndrome relates in part to the type of patients submitted for surgery.
Clearly, the results show that in those patients with single-vessel disease and no prior myocardial infarction or congestive heart failure, there is a much smaller surgical risk than in those with threevessel disease and one or more prior myocardial infarctions. In order to obtain a clear prognosis for saphenous vein bypass surgery, large groups of patients who can easily be divided into the various subcategories must be accumulated and analyzed. While the mortality from coronary arteriography is generally low, this must also be added to surgical mortality for an overall assessment of the procedure. In addition, we have shown that coronary angiography in these critical patients is relatively safe, and that their precarious status contributes little or no added risk to the usual published figures of between 0.1 and 1.0%, 5, 8, 15, 17, 41 Published reports have stated that emergency revascularization "in the properly selected patient," carries no additional operative risk over that of elective bypass.8 Our total experience and that of Effler's group7 are at variance with this point. Elective bypass at Stanford has carried a risk of 1.5% mortality, whereas that for preinfarction angina was 10.4%. This differential between operative mortality is highly significant (P =0.014 by Fisher's exact test).
The six patients with early postinfarction angina do not constitute a large enough group to support broad conclusions, since others have demonstrated a higher mortality in this group. One of these patients died of a technically related intraoperative myocardial infarction. The five surviving patients have experienced excellent benefit from surgery, and none have sustained early or late postoperative infarction nor developed any congestive heart failure. Further surgical trials directed toward early intervention, with the postulate that border tissue to the infarction which is potentially viable can be salvaged, appear indicated in a controlled protocol.
Our experience would support the contemporary view that revascularization is fruitless in those patients with severe chronic congestive heart failure who possess insufficient myocardial reserve. However, a sensitive, specific and objective discriminant function which would preoperatively identify such patients is only now being formalized by us and others.
Although long-term and statistically valid actuarial data regarding the effects of coronary revascularization for preinfarction angina, and the results of randomized, controlled studies, will not be available for several years, we suggest these tentative conclusions based on our 27-month experience:
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